New and emerging approaches to treat psychiatric disorders

KW Scangos, MW State, AH Miller, JT Baker… - Nature medicine, 2023 - nature.com
Psychiatric disorders are highly prevalent, often devastating diseases that negatively impact
the lives of millions of people worldwide. Although their etiological and diagnostic …

Major depressive disorder: advances in neuroscience research and translational applications

Z Li, M Ruan, J Chen, Y Fang - Neuroscience bulletin, 2021 - Springer
Major depressive disorder (MDD), also referred to as depression, is one of the most common
psychiatric disorders with a high economic burden. The etiology of depression is still not …

Building a science of individual differences from fMRI

J Dubois, R Adolphs - Trends in cognitive sciences, 2016 - cell.com
To date, fMRI research has been concerned primarily with evincing generic principles of
brain function through averaging data from multiple subjects. Given rapid developments in …

Machine learning in major depression: From classification to treatment outcome prediction

S Gao, VD Calhoun, J Sui - CNS neuroscience & therapeutics, 2018 - Wiley Online Library
Aims Major depression disorder (MDD) is the single greatest cause of disability and
morbidity, and affects about 10% of the population worldwide. Currently, there are no …

Precision psychiatry: a neural circuit taxonomy for depression and anxiety

LM Williams - The Lancet Psychiatry, 2016 - thelancet.com
Although there have been tremendous advances in the understanding of human
dysfunctions in the brain circuitry for self-reflection, emotion, and cognitive control, a brain …

Targeting glutamate signalling in depression: progress and prospects

JW Murrough, CG Abdallah, SJ Mathew - Nature Reviews Drug …, 2017 - nature.com
Major depressive disorder (MDD) is severely disabling, and current treatments have limited
efficacy. The glutamate N-methyl-d-aspartate receptor (NMDAR) antagonist ketamine was …

Computational psychiatry as a bridge from neuroscience to clinical applications

QJM Huys, TV Maia, MJ Frank - Nature neuroscience, 2016 - nature.com
Translating advances in neuroscience into benefits for patients with mental illness presents
enormous challenges because it involves both the most complex organ, the brain, and its …

Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for …

BW Dunlop, JK Rajendra… - American Journal of …, 2017 - Am Psychiatric Assoc
Objective: The purpose of this article was to inform the first-line treatment choice between
cognitive-behavioral therapy (CBT) or an antidepressant medication for treatment-naive …

Predicting treatment outcomes in major depressive disorder using brain magnetic resonance imaging: a meta-analysis

F Long, Y Chen, Q Zhang, Q Li, Y Wang, Y Wang… - Molecular …, 2024 - nature.com
Recent studies have provided promising evidence that neuroimaging data can predict
treatment outcomes for patients with major depressive disorder (MDD). As most of these …

Defining biotypes for depression and anxiety based on large‐scale circuit dysfunction: A theoretical review of the evidence and future directions for clinical translation

LM Williams - Depression and anxiety, 2017 - Wiley Online Library
Complex emotional, cognitive and self‐reflective functions rely on the activation and
connectivity of large‐scale neural circuits. These circuits offer a relevant scale of focus for …